Impel neuropharma headquarters
WitrynaThis presentation and the accompanying oral commentary by Impel NeuroPharma, Inc. (“we,” “us,” “our,” “Impel” or the “Company”) contains forward-looking statements that … WitrynaDescription. Impel Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize …
Impel neuropharma headquarters
Did you know?
WitrynaImpel Pharmaceuticals Inc. is a Seattle-based, commercial-stage pharmaceutical company developing first-in-class intranasal drug treatments for disorders with high … Witryna10 lut 2024 · Impel NeuroPharma, Inc. is a privately held, Seattle-based biopharmaceutical company focused on developing transformative therapies for …
Witryna6 gru 2024 · SEATTLE, Dec. 6, 2024 /PRNewswire/ -- Impel NeuroPharma ("Impel" or the "Company"), a Seattle -based, privately-held biotechnology company focused on developing therapies for the treatment of ... Witryna12 kwi 2024 · According to the issued ratings of 2 analysts in the last year, the consensus rating for Impel Pharmaceuticals stock is Moderate Buy based on the current 1 hold rating and 1 buy rating for IMPL. The average twelve-month price prediction for Impel Pharmaceuticals is $21.25 with a high price target of $40.00 and a low price target of …
Witryna22 lut 2024 · Impel NeuroPharma is a pharmaceutical company that develops and commercializes therapies for patients suffering from central nervous system diseases. … Witryna9 lis 2024 · Impel NeuroPharma, Inc. is a privately held, Seattle-based biopharmaceutical company focused on developing transformative therapies for people living with central nervous system (CNS) and other ...
WitrynaHeadquarters Regions Greater Seattle Area, West Coast, Western US Founded Date 2008 Founders John Hoekman, Michael Hite, Rodney Ho Operating Status Active Last Funding Type Post-IPO Debt Legal …
Witryna23 kwi 2024 · Impel NeuroPharma's headquarters is located at 201 Elliott Avenue West, Seattle. What is Impel NeuroPharma's latest funding round? Impel … incebWitryna12 kwi 2024 · Its lead product candidate is Trudhesa, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. Impel Pharmaceuticals Inc. was formerly known as Impel NeuroPharma, Inc. and changed its name to Impel Pharmaceuticals Inc. in April 2024. Show more Impel Pharmaceuticals Inc. … incease cpu memory virtualWitryna7 cze 2024 · Impel NeuroPharma, Inc. is a late-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative … in-car speakersWitryna15 lis 2024 · Impel NeuroPharma, Inc. is a commercial-stage biopharmaceutical company developing transformative therapies for people suffering from diseases with … in-car software investmentWitryna5 maj 2024 · Impel NeuroPharma, Inc., is a privately held, Seattle-based biopharmaceutical company which, based on the research of its founder, Chief … incease fps rust gaming laptopWitryna2 cze 2024 · Impel NeuroPharma, Inc. is a late-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for people suffering from diseases with high unmet needs, with an initial focus on diseases of the CNS. The Company’s strategy is to rapidly advance its product … in-car shopWitrynaImpel Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. IMPL updated stock price target summary. inceca it services llc